Insights+: COVID-19 Healthcare News Monthly Updates – April 2020

• Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it
• The outbreak of the respiratory disease was first detected in Wuhan City, Hubei Province, China in Dec 2019
• PharmaShots is keeping a track of all of the important updates in the Lifesciences sector, where we have covered news updates regarding collaborations, clinical trials, funding and regulatory guidelines related to the COVID-19 from Jan to date

APRIL 2020

210. EIB To Provide Israel’s Pluristem with $54M For COVID-19 and Other Cell Therapies

Apr 30, 2020 | Grant

209. INOVIO Expands Manufacturing of INO-4800 With $1.3M Funding from CEPI

Apr 30, 2020 | Grant

208. EMA Initiates Rolling Review of Remdesivir for COVID-19

Apr 30, 2020 | Regulatory

207. EMA to Support Availability of Medicines Amid COVID-19

Apr 30, 2020 | Regulatory

206. Synairgen Receives Approval to Extend SG016 Clinical Study of SNG001 in Patients with COVID-19

Apr 30, 2020 | Clinical Trial

205. Calcimedica Expands Clinical Study to Evaluate CM4620-IE In Patients With Covid-19 Pneumonia On High-Flow Oxygen Therapy

Apr 30, 2020 | Clinical Trial

204. Integral Molecular Develops Test for Neutralizing AB in Patients with COVID-19

Apr 30, 2020 | Diagnostic

203. Pfizer to Develop 10-20M doses of vaccine By End of 2020

Apr 30, 2020 | Pharma

202. Global Pharma Accelerate the Development of New Treatments to Combat COVID-19

Apr 30, 2020 | Pharma

201. NICE Joins International Collaboratives to Combat COVID-19 Pandemic

Apr 30, 2020 | Collaboration

200. Mesoblast Commences the Enrollment in P-II/III Study of Remestemcel-L in Patients with COVID-19

Apr 30, 2020 | Clinical Trial

199. MUSC and HPE Make Innovative Drug Discovery Software Publicly Available In Response To Covid-19 Crisis

Apr 30, 2020 | DigiHealth

198. FUJIFILM Diosynth Biotechnologies to Reserve Manufacturing Capacity to Deliver COVID-19 Therapies

Apr 30, 2020 | Clinical Trial

197. ACAMP in Collaboration with University of Alberta Develops Plastic Respirators to Prevent Spread of Covid-19

Apr 29, 2020 | Collaboration

196. BIOTECON Diagnostics Launches Microproof kits for Covid-19

Apr 29, 2020 | Diagnostic

195. SeaStar Medical to Initiate a Study of Selective Cytopheretic Device in COVID-19 patients

Apr 29, 2020 | Clinical Trial

194. ERBA Mannheim Launches CE Marked COVID-19 Antibody ELISA Kits

Apr 29, 2020 | Diagnostic

193. Genalyte Reports Availability of its High-Speed COVID-19 Antibody Test

Apr 29, 2020 | Diagnostic

192. Accurate Diagnostic Labs Reports The Availability of Serological Antibody Test This Week

Apr 29, 2020 | Diagnostic

191. BioIQ and Matrix Medical Network Report the Availability of COVID-19 Testing Program for US Employers

Apr 29, 2020 | Diagnostic

190. IIT Guwahati collaborates with Hester Biosciences for Covid-19 Vaccine

Apr 29, 2020 | Collaboration

189. Montefiore and Albert Einstein College of Medicine Partner with NYU Langone Health to Determine if Convalescent Plasma can Treat COVID-19

Apr 29, 2020 | Collaboration

188. Chimerix Reports Initiation of a P-II/III Study of DSTAT in Acute Lung Injury for Patients with Severe COVID-19

Apr 29, 2020 | Clinical Trial

187. UQ Reports Preclinical Data of its COVID-19 Vaccine Candidate

Apr 29, 2020 | Clinical Trial

186. Verndari Initiates Preclinical Testing of COVID-19 Vaccine at University of California

Apr 29, 2020 | Clinical Trial

185. Treatments for COVID-19 Could Be Fast-Tracked Through New National Clinical Trial Initiative in the UK

Apr 29, 2020 | Regulatory

184. QLHC Collaborates with Sponsor of the Adaptive Platform I-Spy 2 Trial to Identify Therapies Targeting ARDS Associated with COVID-19

Apr 29, 2020 | Collaboration

183. BeiGene Collaborates with Atreca and IGM Biosciences to Develop Antibody Treatment Targeting COVID-19

Apr 29, 2020 | Collaboration

182. Formycon Initiates Antibody-Based Drug Development Against COVID-19

Apr 29, 2020 | Clinical Trial

181. Algernon Receives Health Canada Approval to Initiate P-IIb/III of Ifenprodil Against COVID-19  

Apr 29, 2020 | Clinical Trial

180. BioNTech and Pfizer Complete Dosing of BNT162 in First Cohort of P-I/II Study in Germany

Apr 29, 2020 | Clinical Trial

179. Novartis Plans to Commence P-III Clinical Study Evaluating Canakinumab for Patients with COVID-19 Pneumonia

Apr 28, 2020 | Clinical Trial

178. AIIMS Plans to Conduct Clinical Trial of Plasma Therapy Treating COVID-19

Apr 28, 2020 | Clinical Trial

177. Shionogi Facilitates the Development of Potential Treatments and Vaccine Against COVID-19

Apr 28, 2020 | Clinical Trial

176. Japan to Provide its Avigan to Thirty-Eight Countries As Early As This Week

Apr 28, 2020 | Grant

175. Secarna Pharmaceuticals Collaborate with Guangzhou’s Sun Yat-sen University to Develop a Treatment for COVID-19

Apr 28, 2020 | Collaboration

174.VistaGen Expands Clinical Development of PH94B to Include Adjustment Disorder Associated with COVID-19

Apr 28, 2020 | Clinical Trial

173. Sarepta Signs a Research Agreement with the US Department of Defense to Identify Antisense Oligonucleotides Against COVID-19

Apr 28, 2020 | Collaboration

172. The Serum Institute of India to Produce Millions of Potential Coronavirus Vaccine Doses

Apr 28, 2020 | Clinical Trial

171. PharmaMar Initiates Clinical Study with Aplidin For Potential Treatment Of COVID-19

Apr 28, 2020 | Clinical Trial

170. Global Pandemic Consortium Supports Trump’s Call for Evaluating UV Light as a Potential Treatment for COVID 19

Apr 28, 2020 | Collaboration

169. Invivoscribe Launches Diagnostic Test with an Option To Participate In SARS-CoV-2 Ab and Vaccine Program

Apr 28, 2020 | Diagnostic

168. Innate Pharma Reports First Patient Dosing of Avdoralimab in P-II Clinical Study in COVID-19 Patients With Severe Pneumonia

Apr 28, 2020 | Clinical Trial

167. Cromos Pharma Supports R-Pharm in Initiation of a Global Program to Test Olokizumab and RPH-104 in Patients with Severe COVID-19

Apr 28, 2020 | Clinical Trial

166. CEPI Collaborates with Clover to Support the Development of Vaccine Against COVID-19 in Australia

Apr 27, 2020 | Collaboration

165. ViiV Healthcare to Fund $3.24 to the Research Evaluating the Impact of COVID-19 on the HIV Community

Apr 27, 2020 | Grant

164. Innovation to Initiate the Testing of Brilacidin Against COVID-19 by the Week of May 4, 2020

Apr 27, 2020 | Clinical Trial

163. Kamada and Kedrion Biopharma Collaborate for Plasma-Derived Anti-SARS-CoV-2 Polyclonal Immunoglobulin Product

Apr 27, 2020 | Collaboration

162. HHS Launches COVID-19 Uninsured Program Portal

Apr 27, 2020 | DigiHealth

161. Mateon Reports Submission of IND to The US FDA for Evaluating Its OT-101 in Patients with COVID-19

Apr 27, 2020 | Clinical Trial

160. Romark to Initiate P-III Clinical Study Evaluating NT-300 For COVID-19

Apr 27, 2020 | Clinical Trial

159. Regeneron and Sanofi Provide Update of P-II/III Adaptive-Designed Trial of Kevzara in Hospitalized Patients with COVID-19 in the US

Apr 27, 2020 | Clinical Trial

158.  Capital Health Launches Antibody Testing Initiative for COVID-19

Apr 27, 2020 | Launch

157. Santhera Signs a Clinical Trial Agreement with Cold Spring Harbor Laboratory to Evaluate Lonodelestat (POL6014) Against Acute Respiratory Distress Syndrome Associated with COVID-19

Apr 27, 2020 | Clinical Trial

156. Kainos Medicine to Evaluate Compound Similar to Remdesivir as Treatment for COVID-19

Apr 26, 2020 | Clinical Trial

155. Serum Institute to Initiate Manufacturing of Oxford University’s COVID-19 Vaccine in Next 2-3 Weeks

Apr 25, 2020 | Clinical Trial

154. Wuhan Institute of Biological Products Inactivated COVID-19 Vaccine Enters In P-II Clinical Study

Apr 25, 2020 | Clinical Trial

153. UK Approves Clinical Study for Utilizing Plasma from Recovered Patients

Apr 25, 2020 | Clinical Trial

152. Biopharma to Initiate Clinical Study Evaluating Ab Against COVID-19 in Ukraine

Apr 24, 2020 | Clinical Trial

151. Global Leaders Collaborate to Make COVID-19 Testing and Treatment Available for All

Apr 24, 2020 | Collaboration

150. . WHO/Europe Publishes Considerations for Gradual Easing of Lockdown Restrictions across the European Region

Apr 24, 2020 | Regulatory

149. Janssen Collaborates with Emergent BioSolutions to Accelerate the Manufacturing of its Vaccine Against COVID-19

Apr 24, 2020 | Collaboration

148. Vela Diagnostics Receives CE mark for its ViroKey SARS-CoV-2 RT-PCR Test

Apr 24, 2020 | Diagnostic

147. ALung Receives the US FDA’s EUA for Hemolung Respiratory Assist System to Treat COVID-19

Apr 24, 2020 | Regulatory

146. Siemens Healthineers to Expand Sars-Cov-2 Testing to Include a Total Ab Test Targeting Covid-19 Pandemic

Apr 23, 2020 | Diagnostic

145. Enzo Biochem Launches Diagnostic Test for COVID-19 Under EUA

Apr 23, 2020 | Diagnostic

144. ReiThera Collaborates with Leukocare and Univercells to Fast-Track the Development of COVID-19 Vaccine

Apr 23, 2020 | Collaboration

143. NEC Publishes Design Blueprints for COVID-19 Vaccines Utilizing Artificial Intelligence

Apr 23, 2020 | DigiHealth

142. Arch Biopartners Reports Submission of Application to Health Canada for Conducting P-II Study of Metablok to Prevent Lung and Kidney Inflammation Associated with COVID19

Apr 23, 2020 | Regulatory

141. Human Vaccines Project Launches Global Initiative to Facilitate the Development of COVID-19 Vaccines

Apr 23, 2020 | Launch

140. NIH Unveils the Strategic Plan for Accelerating Research to Diagnose, Prevent and Treat COVID-19

Apr 23, 2020 | Regulatory

139. Insmed to Support Stop-Covid19 Study Evaluating Brensocatib (Formerly Ins1007) in Patients with Severe COVID-19

Apr 23, 2020 | Clinical Trial

138. ViralClear Publishes Comparative In Vitro Data on Merimepodib and Remdesivir Activity Against the COVID-19 Novel Coronavirus in F1000 Research

Apr 23, 2020 | Clinical Trial

137. Cytovance Biologics and Akshaya Bio Announce Collaborate for Coronavirus And Hepatitis B Virus Infections

Apr 23, 2020 | Collaboration

136. Algernon Receives Regulatory and Ethics Approval for P-II Study Evaluating Ifenprodil for COVID-19 in South Korea

Apr 23, 2020 | Clinical Trial

135. Hemogenyx To Utilize Its Advanced Humanized Mice to Develop Potential Treatments for COVID-19

Apr 23, 2020 | Clinical Trial

134. NICE Publishes Two New Guidelines for COVID-19

Apr 23, 2020 | Regulatory

133. Swiss Hospitals Launches Clinical Study to Prevent Covid-19 Infection

Apr 23, 2020 | Clinical Trial

132. Theravance Reports First Patient Dosing in P-I Study with TD-0903 to Treat Patients with Acute Lung Injury Associated with COVID-19

Apr 23, 2020 | Clinical Trial

131. Mobidiag Receives Emergency Use Authorization for its Automated COVID-19 Test in Finland

Apr 23, 2020 | Diagnostic

130. LabCorp Receives the US FDA’s Emergency Use Authorization for its COVID-19 At-Home Test Kit

Apr 23, 2020 | Diagnostic

129.  AstraZeneca and Saint Luke’s Mid America Heart Institute to Initiate P-III DARE-19 Evaluating Farxiga Against COVID-19

Apr 23, 2020 | Clinical Trial

128. Moleculin Reports Head of NIAID Antiviral Drug Discovery and Development Center Joins its COVID-19 Drug Development Team

Apr 22, 2020 | Pharma

127. Biovista Identified Four Treatment Against COVID-19 Utilizing its AI Platfrom

Apr 22, 2020 | Clinical Trial

126. Nuritas Deploys AI Platform to Identify Therapeutic Peptides Against COVID-19

Apr 22, 2020 | DigiHealth

125. Oncology Venture to Evaluate its 2X-121 as a Potential Therapy for COVID-19

Apr 22, 2020 | Clinical Trial

124. Precision For Medicine Collaborates with Karyopharm Therapeutics to Initiate Global Clinical Trial To Treat Patients with COVID-19

Apr 22, 2020 | Collaboration

123.  Valneva and Dynavax Collaborate to Advance the Development of Vaccine Against COVID-19

Apr 22, 2020 | Collaboration

122.  Pfizer and BioNTech to Commence Clinical Study for COVID-19 in Germany

Apr 22, 2020 | Clinical Trial

121. NIH Issues Guidelines for the Treatment of COVID-19

Apr 21, 2020 | Regulatory

120. Vivacelle Bio Reports the Compassionate Use of its VBI-S in Patients with COVID-19

Apr 21, 2020 | Regulatory

119. Edesa Biotech Sign License Agreement with Light Chain Bioscience to Develop Treatments for COVID-19 Pneumonia and Other Disorders

Apr 21, 2020 | Collaboration

118.